Evaluating Alzheimer's Disease Progression by Modeling Crosstalk Network Disruption

被引:6
|
作者
Liu, Haochen [1 ]
Wei, Chunxiang [1 ]
He, Hua [1 ]
Liu, Xiaoquan [1 ]
机构
[1] China Pharmaceut Univ, Ctr Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China
来源
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; disease progression; crosstalk network; diagnosis; multi-marker; CSF BIOMARKERS; TAU PATHOLOGY; REPRESENTATION; DIAGNOSIS; DECLINE; MARKERS;
D O I
10.3389/fnins.2015.00523
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A beta, tau, and P-tau have been widely accepted as reliable markers for Alzheimer's disease (AD). The crosstalk between these markers forms a complex network. AD may induce the integral variation and disruption of the network. The aim of this study was to develop a novel mathematic model based on a simplified crosstalk network to evaluate the disease progression of AD. The integral variation of the network is measured by three integral disruption parameters. The robustness of network is evaluated by network disruption probability. Presented results show that network disruption probability has a good linear relationship with Mini Mental State Examination (MMSE). The proposed model combined with Support vector machine (SVM) achieves a relative high 10 fold cross validated performance in classification of AD vs. normal and mild cognitive impairment (MCI) vs. normal (95% accuracy, 95% sensitivity, 95% specificity for AD vs. normal; 90% accuracy, 94% sensitivity, 83% specificity for MCI vs. normal). This research evaluates the progression of AD and facilitates AD early diagnosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Evaluating functional connectivity of executive control network and frontoparietal network in Alzheimer's disease
    Zhao, Qinghua
    Lu, Hong
    Metmer, Hichem
    Li, Will X. Y.
    Lu, Jianfeng
    BRAIN RESEARCH, 2018, 1678 : 262 - 272
  • [42] Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
    Small, David H.
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (03) : 103 - 108
  • [43] Assessing disease progression in Alzheimer's disease
    Katzourou, I.
    Holmans, P.
    Williams, J.
    Escott-Price, V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 31 : S61 - S62
  • [44] Disruption of Calcium Homeostasis in Alzheimer's Disease
    Korol', T. Yu.
    Korol', S. V.
    Kostyuk, E. P.
    Kostyuk, P. G.
    NEUROPHYSIOLOGY, 2008, 40 (5-6) : 385 - 392
  • [45] Circadian Disruption Associated with Alzheimer's Disease
    Saeed, Yumna
    Abbott, Sabra M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (04)
  • [46] Disruption of Calcium Homeostasis in Alzheimer’s Disease
    T. Yu. Korol’
    S. V. Korol’
    E. P. Kostyuk
    P. G. Kostyuk
    Neurophysiology, 2008, 40 : 385 - 392
  • [47] Circadian Disruption Associated with Alzheimer’s Disease
    Yumna Saeed
    Sabra M . Abbott
    Current Neurology and Neuroscience Reports, 2017, 17
  • [48] A Machine Learning Approach to Evaluating the Impact of Natural Oils on Alzheimer's Disease Progression
    Amawi, Rema M.
    Al-Hussaeni, Khalil
    Keeriath, Joyce James
    Ashmawy, Naglaa S.
    APPLIED SCIENCES-BASEL, 2024, 14 (15):
  • [49] Disruption of zinc homeostasis in Alzheimer's disease
    Robertson, JD
    Crafford, AM
    Markesbery, WR
    Lovell, MA
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS, 2002, 189 : 454 - 458
  • [50] Crosstalk in Alzheimer disease
    Leake I.
    Nature Reviews Neuroscience, 2019, 20 (9) : 513 - 513